Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . March 22nd, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chronic Hepatitis C Therapy - Marmosets infected with GB virus B are a surrogate model for HCV infection
Liver Disease - Patients with hepatitis B virus genotype C experience delayed seroconversion
Chronic Hepatitis B Therapy - Extended periods of undetectable HBV DNA bode well for nonrelapse after therapy
Diagnostics - Mimotopes could be valuable for diagnosing hepatitis C virus infection
Oncology - Hepatitis B virus X protein makes mice more susceptible to carcinogens
Virology - Low doses of woodchuck hepatitis virus target the lymphatic system
Acute Drug Effects - Arthritis patients with rare polymorphisms risk acute hepatitis with leflunomide
Adverse Drug Effects - Tumor necrosis factor signals mediate acetaminophen-induced liver injury
Biotechnology - DNA chip offers simultaneous detection of HIV, HBV and HCV in blood
Chronic Hepatitis C - IRES variability has no influence on hepatitis C virus response to therapy
Finance - Biotech company announces closing of private placement
Finance - Zadaxin maker reports 2003 financial results
Hepatitis - Novel HEV strain identified in Namibia outbreak
Hepatitis B Vaccine - Hepatitis B vaccine induces higher antibody responses in newborns than adults
Hepatitis C Vaccine - DNA vaccine enhances Th1 immune response against hepatitis C virus
Hepatitis C Virus - FDA issues approvable letter for ribavirin capsules
Hepatitis E Virus - Genetic changes and strain takeover mark HEV genotype variability in India
Hepatology - Liver-specific promoter directs potent therapeutic gene expression
Immunology - Mutations in hepatitis B core epitopes alter the way CD4+ T cells act
Legal Issues - Feds review complaints that Chiron hinders research
Liver Transplant - Civacir phase I/II trial completed, preliminary results encouraging
Metabolic Syndrome - Liver disease is common in patients treated in metabolic departments
Personnel - R&D company announces new member of board of directors
Pharmaceutical & Drug Development - Bis(Maltolato)zinc(II) complex treats injured livers in mice
Transplant Medicine - Gene therapy protects livers from transplant-related injury
Viral Genomics - The hypervariable region of HCV E2 evolves after selective pressure
Virology - Cytotoxic T cells from HCV patients use Fas-FasL to kill bystander cells
Virology - Immune-mediated clearance of neonatal woodchuck hepatitis virus falls short
Virology - RNA molecules play important role as antiviral agents for cell treatment
Virology - The hepatitis C virus core protein is key to virus-host interactions
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
